[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:fibroblast-growth-factor-receptor-family":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Fibroblast Growth Factor Receptor Family",6,4,[8,16,23,29,35,43],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06906562","A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations",[12],"Phase 2","RECRUITING","2026-08-26T02:16:15.345907Z","2026-05-05T02:43:29.157055Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06319820","A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer",[20],"Phase 3","2026-08-26T02:17:47.813245Z","2026-05-05T02:43:29.030151Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06263153","Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy",[12],"2026-08-26T02:17:16.126291Z","2026-05-05T02:43:27.135215Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06919965","A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer",[20],"2026-08-26T02:18:46.948970Z","2026-05-05T02:35:31.753313Z",{"nct_id":36,"title":37,"phases":38,"status":40,"updated_at":41,"content_modified":42},"NCT04092673","Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies",[39],"Phase 1\u002FPhase 2","UNKNOWN","2026-08-03T03:49:37.452409Z","2026-05-05T02:43:28.655464Z",{"nct_id":44,"title":45,"phases":46,"status":48,"updated_at":49,"content_modified":50},"NCT06506955","Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.",[47],"Phase 2\u002FPhase 3","ACTIVE_NOT_RECRUITING","2026-08-03T02:00:40.724107Z","2026-06-16T05:54:07.756160Z"]